Stock Analiz

eHealth, Inc. EHTH

Specialty Insurers · IPO 2006 · data as of November 13, 2026

$0.41Market cap $13M
Open the interactive analysis →

eHealth, Inc. (EHTH) is a financial company listed in the US with a market value of about $13M. In the twelve months to September 30, 2026 it had revenue of $469M and net income of $23M, a net margin of 4.9%.

Its overall Stock Analiz score is 1.8 out of 5 (weak). The strongest part is value (3/5); the weakest is track record (0/5).

Key numbers: a P/E of 0.6, 5-year revenue growth of -1% a year, a 5-year average ROIC of -4%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 250% above the current price.

About eHealth

eHealth is listed in the US and classified in specialty insurers, IPO year 2006. Revenue went from $180M in 2014 to $554M in 2025, growth of about 10.8% a year. It was profitable in 7 of the last 10 years in our data. Its share count rose by 11% over three years (dilution for shareholders). It spends 2% of revenue on research and development.

Score: 1.8 / 5

Value3/5
Future growth2/5
Track record0/5
Financial health3/5
Shareholder returns1/5

Checks passed

  • P/E below 25
  • P/E below the industry median
  • Price below intrinsic value (DCF, moderate assumptions)
  • 3-year revenue growth above 10% a year
  • Profit margin improving
  • More cash than debt, or low debt to equity
  • Interest covered more than 5 times
  • Liabilities below 60% of assets

Checks not passed

  • P/FCF below 20
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year free cash flow growth above 10% a year
  • Strong R&D investment or growth above 20%
  • 5-year EPS growth above 10% a year
  • 5-year revenue growth above 8% a year
  • 5-year average ROIC above 12%

Valuation

P/E (TTM)0.6
Forward P/E—
P/FCF—
P/S0.0
P/B0.0
EV/EBITDA1.1
PEG—
Dividend yield—
FCF yield-128.4%
Shareholder yield0.0%
Intrinsic value vs. price+250%

Growth and quality

Revenue growth (1 yr)4.1%
Revenue growth (5 yrs, per year)-1.0%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-7.7%
ROIC (5-yr avg.)-4.1%
Profitable years (of last 10)7
Years paying a dividend1

Financials, last 10 years

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$469M$554M$532M$453M$405M$538M$583M$506M$251M$191M$193M
Net income$23M$40M$10M-$28M-$89M-$104M$45M$67M$241000$25M$304000
Free cash flow-$17M-$28M-$20M-$9M-$27M-$166M-$116M-$78M-$8M-$17M$2M
EPS (diluted)$0.71$-0.34$-1.19$-2.37$-4.36$-4.59$1.68$2.73$0.01$1.33$0.02
Net margin4.9%7.2%1.9%-6.2%-21.9%-19.4%7.8%13.2%0.1%13.3%0.2%
ROIC—6.2%1.8%-3.8%-11.3%-13.3%5.1%11.5%0.7%-2.6%0.9%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

What is eHealth’s P/E ratio?

About 0.6, based on the last twelve months of diluted earnings per share.

Is eHealth stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 250% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does eHealth pay a dividend?

Not currently.

Is eHealth a good stock to buy?

We do not give buy or sell advice. eHealth scores 1.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.